Trial Profile
PHASE II STUDY ON PEMETREXED IN ADVANCED AND/OR RECURRENT CERVICAL CANCER.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jun 2011
Price :
$35
*
At a glance
- Drugs Pemetrexed (Primary)
- Indications Cervical cancer
- Focus Therapeutic Use
- 14 Jun 2011 New trial record